StockStory.org on MSN
Life sciences tools & services stocks Q4 earnings: Illumina (NASDAQ:ILMN) firing on all cylinders
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.
Last month in Redwood Shores, Calif., participants in the National Conference of Biotechnology Ventures decided to have some fun. Venture capitalists and biotech CEOs lined up to play a corporate ...
At this year’s ABRF Annual Meeting (23–26 March; NV, USA), biotech companies had the opportunity to showcase their technology, highlighting how their products are facilitating breakthroughs in the ...
Ark Invest CEO Cathie Wood is doubling down on genomics. What Happened: Pacific Biosciences of California Inc. (NASDAQ:PACB), known as PacBio, is biotech’s new kid on the block. The company's Vega ...
After taking a shot at becoming a neuroscience biotech, buzzy Bay Area AI outfit Verge Genomics is dropping its only clinical asset and returning to its drug discovery roots. The decision comes after ...
Raymond James Financial Inc. purchased a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report) in the fourth quarter, HoldingsChannel reports. The fund purchased ...
Hosted on MSN
Three genomics stocks worth tracking this year
An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
LAUSANNE, Switzerland--(BUSINESS WIRE)--Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of a CHF 2.8 million ($3.2 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results